Logo image of BBH

VANECK BIOTECH ETF (BBH) Stock Overview

USA - NASDAQ:BBH - US92189F7261 - ETF

167.576 USD
+0.05 (+0.03%)
Last: 9/19/2025, 8:00:01 PM
Fundamental Rating

4

Overall BBH gets a fundamental rating of 4 out of 10. We evaluated BBH against 80 industry peers in the Automobile Components industry. BBH has an average financial health and profitability rating. BBH is valied quite expensively at the moment, while it does show a decent growth rate. BBH also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BBH had positive earnings in the past year.
BBH had a positive operating cash flow in the past year.
Each year in the past 5 years BBH has been profitable.
Each year in the past 5 years BBH had a positive operating cash flow.
BBH Yearly Net Income VS EBIT VS OCF VS FCFBBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

BBH's Return On Assets of 4.39% is in line compared to the rest of the industry. BBH outperforms 45.00% of its industry peers.
Looking at the Return On Equity, with a value of 8.81%, BBH is in line with its industry, outperforming 42.50% of the companies in the same industry.
With a Return On Invested Capital value of 8.17%, BBH perfoms like the industry average, outperforming 41.25% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BBH is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
BBH Yearly ROA, ROE, ROICBBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 5.84%, BBH is in line with its industry, outperforming 47.50% of the companies in the same industry.
In the last couple of years the Profit Margin of BBH has remained more or less at the same level.
With a Operating Margin value of 10.65%, BBH perfoms like the industry average, outperforming 48.75% of the companies in the same industry.
BBH's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 27.60%, BBH is in line with its industry, outperforming 41.25% of the companies in the same industry.
BBH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
BBH Yearly Profit, Operating, Gross MarginsBBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BBH is still creating some value.
BBH has less shares outstanding than it did 1 year ago.
BBH has less shares outstanding than it did 5 years ago.
BBH has a worse debt/assets ratio than last year.
BBH Yearly Shares OutstandingBBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BBH Yearly Total Debt VS Total AssetsBBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 5.24 indicates that BBH is not in any danger for bankruptcy at the moment.
BBH has a Altman-Z score of 5.24. This is amongst the best in the industry. BBH outperforms 87.50% of its industry peers.
The Debt to FCF ratio of BBH is 6.05, which is on the high side as it means it would take BBH, 6.05 years of fcf income to pay off all of its debts.
BBH has a Debt to FCF ratio of 6.05. This is in the lower half of the industry: BBH underperforms 66.25% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that BBH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.32, BBH is doing worse than 63.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 5.24
ROIC/WACC1.07
WACC7.61%
BBH Yearly LT Debt VS Equity VS FCFBBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.80 indicates that BBH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.80, BBH is doing worse than 75.00% of the companies in the same industry.
BBH has a Quick Ratio of 1.12. This is a normal value and indicates that BBH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.12, BBH is doing worse than 76.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
BBH Yearly Current Assets VS Current LiabilitesBBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The earnings per share for BBH have decreased strongly by -18.28% in the last year.
BBH shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.64% yearly.
Looking at the last year, BBH shows a decrease in Revenue. The Revenue has decreased by -3.62% in the last year.
BBH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.41% yearly.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

Based on estimates for the next years, BBH will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.31% on average per year.
Based on estimates for the next years, BBH will show a small growth in Revenue. The Revenue will grow by 2.56% on average per year.
EPS Next Y22.75%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
EPS Next 5YN/A
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BBH Yearly Revenue VS EstimatesBBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
BBH Yearly EPS VS EstimatesBBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 64.70 indicates a quite expensive valuation of BBH.
Compared to the rest of the industry, the Price/Earnings ratio of BBH indicates a slightly more expensive valuation: BBH is more expensive than 76.25% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BBH to the average of the S&P500 Index (27.38), we can say BBH is valued expensively.
Based on the Price/Forward Earnings ratio of 37.92, the valuation of BBH can be described as expensive.
78.75% of the companies in the same industry are cheaper than BBH, based on the Price/Forward Earnings ratio.
BBH is valuated expensively when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 64.7
Fwd PE 37.92
BBH Price Earnings VS Forward Price EarningsBBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BBH is valued a bit more expensive than the industry average as 77.50% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, BBH is valued a bit more expensive than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 80.7
EV/EBITDA 21.44
BBH Per share dataBBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as BBH's earnings are expected to grow with 16.31% in the coming years.
PEG (NY)2.84
PEG (5Y)39.38
EPS Next 2Y19.47%
EPS Next 3Y16.31%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.38%, BBH is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.89, BBH pays a better dividend. On top of this BBH pays more dividend than 96.25% of the companies listed in the same industry.
BBH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.38%

5.2 History

On average, the dividend of BBH grows each year by 7.84%, which is quite nice.
BBH has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BBH decreased recently.
Dividend Growth(5Y)7.84%
Div Incr Years1
Div Non Decr Years1
BBH Yearly Dividends per shareBBH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

62.40% of the earnings are spent on dividend by BBH. This is not a sustainable payout ratio.
BBH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
BBH Yearly Income VS Free CF VS DividendBBH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
BBH Dividend Payout.BBH Dividend Payout, showing the Payout Ratio.BBH Dividend Payout.PayoutRetained Earnings

VANECK BIOTECH ETF

NASDAQ:BBH (9/19/2025, 8:00:01 PM)

167.576

+0.05 (+0.03%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners39.91%
Inst Owner Change-21.62%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap118.27B
Analysts80.87
Price Target203.77 (21.6%)
Short Float %0%
Short Ratio1.11
Dividend
Industry RankSector Rank
Dividend Yield 4.38%
Yearly Dividend1.59
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.6%
PT rev (3m)21.91%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.31%
EPS NY rev (3m)-9.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE 64.7
Fwd PE 37.92
P/S 3.74
P/FCF 80.7
P/OCF 29.58
P/B 5.65
P/tB 7.67
EV/EBITDA 21.44
EPS(TTM)2.59
EY1.55%
EPS(NY)4.42
Fwd EY2.64%
FCF(TTM)2.08
FCFY1.24%
OCF(TTM)5.66
OCFY3.38%
SpS44.78
BVpS29.68
TBVpS21.85
PEG (NY)2.84
PEG (5Y)39.38
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 5.24
F-Score5
WACC7.61%
ROIC/WACC1.07
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y22.75%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year66.93%
EBIT Next 3Y23.28%
EBIT Next 5Y17.51%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%